The APD6 database now catalogs over 5,188 antimicrobial peptides and introduces a comprehensive information pipeline to accelerate the development of peptide-based antibiotics.
5,188 peptides catalogedThe largest curated antimicrobial peptide database, including natural, synthetic, and AI-predicted peptides with new datasets for advanced AI modeling
What the researchers found
The APD6 platform now houses 5,188 peptide records, broken down into 3,306 natural, 1,380 synthetic, and 239 predicted antimicrobial peptides. The database introduces the most comprehensive antimicrobial peptide information pipeline (AMPIP) to date, covering the full research lifecycle from discovery through clinical trials. New positive and negative datasets for factors like pH stability, salt tolerance, serum effects, and resistance potential have been added to support more advanced AI prediction models beyond the current focus on activity and hemolysis alone.
Why it matters
With antibiotic resistance recognized as a major global health threat, antimicrobial peptides represent one of the most promising paths to next-generation antibiotics. A centralized, comprehensive database like APD6 accelerates research by giving scientists ready access to curated peptide data, AI-training datasets, and clinical pipeline information — potentially shortening the timeline from peptide discovery to therapeutic use.
How the study worked
The researchers consolidated and expanded an existing peptide database platform, curating peptide records from published literature and computational predictions. They refined classification schemes for natural, synthetic, and predicted antimicrobial peptides, and built an information pipeline that systematically organizes data from discovery through clinical application.
What this study cannot tell us
The database relies on published literature, so peptides from unpublished or proprietary research are not included. AI prediction datasets are still limited compared to the complexity of real-world therapeutic development. The database catalogs peptide properties but does not replace the need for experimental validation of any individual peptide's clinical potential.
How to read the evidence
This is a database and resource paper rather than a clinical or experimental study. It provides infrastructure for research rather than direct evidence of therapeutic outcomes.
When this study was published
Published in 2026 with data current through March 2025, this represents the most up-to-date resource in the antimicrobial peptide database field.
The bigger picture
This database update arrives at a critical time when antibiotic resistance is driving urgent demand for alternative antimicrobial strategies. By providing curated datasets specifically designed for AI model training, APD6 bridges the gap between traditional peptide research and modern computational drug discovery. The expanded functional categories — including anticancer and antidiabetic peptides — also signal the broadening therapeutic potential of peptides well beyond fighting infections.
Questions still open
- How quickly can the new AI-ready datasets accelerate the identification of clinically viable antimicrobial peptides?
- Will the expanded functional categories (anticancer, antidiabetic) lead to significant peptide therapeutic development outside the antibiotic space?
- How does the inclusion of resistance-related data change the way researchers prioritize candidate peptides for development?
Common questions
What is the Antimicrobial Peptide Database (APD6)?
Why are antimicrobial peptides important for fighting antibiotic resistance?
Read the original research
APD6: the antimicrobial peptide database is expanded to promote research and development by deploying an unprecedented information pipeline.
Nucleic acids research, 54(D1), D363-D374
Citation
Wang, Guangshun; Schmidt, Cindy; Li, Xia; Wang, Zhe. (2026). APD6: the antimicrobial peptide database is expanded to promote research and development by deploying an unprecedented information pipeline.. Nucleic acids research, 54(D1), D363-D374. https://doi.org/10.1093/nar/gkaf860